Contribution of epithelial-mesenchymal transition to pancreatic cancer progression

Seth B. Krantz, Mario A. Shields, Surabhi Dangi-Garimella, David J. Bentrem, Hidayatullah G. Munshi

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations


Pancreatic adenocarcinoma (PDAC) is one of the most lethal human malignancies, with median survival of less than one year and overall five-year survival of less than 5%. There is increasing evidence demonstrating that epithelial-mesenchymal transition (EMT) contributes to pancreatic cancer metastasis and to treatment resistance. In this review, we will examine the data demonstrating the role and regulation of EMT in pancreatic cancer progression, focusing particularly on the transcription factors and microRNAs involved in EMT. We will examine how EMT is involved in the generation and maintenance of stem cells, and the role of EMT in modulating resistance of PDAC cells to drug therapies. We will also identify putative EMT-targeting agents that may help to reduce the morbidity and mortality associated with pancreatic cancer.

Original languageEnglish (US)
Pages (from-to)2084-2097
Number of pages14
Issue number4
StatePublished - Dec 2010


  • Epithelial-mesenchymal transition microRNA
  • Pancreatic cancer
  • Stem cells drug resistance

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Contribution of epithelial-mesenchymal transition to pancreatic cancer progression'. Together they form a unique fingerprint.

Cite this